13 results on '"Martijn C.G.J. Brouwers"'
Search Results
2. Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study
- Author
-
Zhewen Ren, Hans Bosma, Anke Wesselius, Simone J.P.M. Eussen, M. Eline Kooi, Carla J.H. van der Kallen, Annemarie Koster, Marleen M.J. van Greevenbroek, Pieter Dagnelie, Coen D.A. Stehouwer, and Martijn C.G.J. Brouwers
- Subjects
Intrahepatic lipid content ,Lifestyle ,Mediation analysis ,Non-alcoholic fatty liver disease ,Socioeconomic ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Recent studies have unveiled an association between socioeconomic position (SEP) and intrahepatic lipid (IHL) content. The aim of this study was to examine to what extent traditional lifestyle factors mediate the relationship between SEP and IHL content, independent of aetiology, and non-alcoholic fatty liver disease (NAFLD). Methods: We used cross-sectional data derived from The Maastricht Study (N = 4,001; mean age: 60 years, 49% women, 32% low education level, 21% diabetes, 21% NAFLD). Education, income, and occupation were used as indicators of SEP. Physical activity (accelerometer), intake of total energy, alcohol, saturated fat, protein, vitamin E, dietary fibre, and fructose from sugar-sweetened beverages (SSBs) and fruit juice (food frequency questionnaires) were potential mediators. IHL content was quantified by magnetic resonance imaging. Age, sex, and type 2 diabetes were covariates. Multiple parallel mediation analyses (bootstraps = 10,000) were performed. Results: Individuals with a low education level had a 1.056-fold higher IHL content (95% CI: 1.03–1.08) and a 44% greater NAFLD risk (OR:1.44; 95% CI:1.18–1.77) compared with those with higher education levels. Approximately 8.9% of educational disparity in risk of IHL content was attributable to moderate-to-vigorous physical activity; 6.3% to fructose intake from SSBs; 5.5% to dietary fibre; and -23% to alcohol. Approximately 8.7% of educational disparity in risk of NAFLD was attributable to moderate-to-vigorous physical activity; and 7.7% to fructose intake from SSBs. However, the indirect effect of these mediators was small (0.998 for IHL content and 1.045 for NAFLD) in comparison to the total effect. Similar results were found when income and occupation were used as SEP indicators. Conclusions: Societal measures may alleviate the burden of NAFLD and further studies that identify mediators other than traditional lifestyle factors are warranted to define the relationship underlying SEP and IHL content. Impact and implications: Individuals with a low or medium level of education, income, or occupational status had more fat accumulation in their livers than individuals with a higher education, income, or occupational status. This difference may be attributed to the influence of unhealthy lifestyle factors, such as reduced physical activity and a higher intake of sugar-sweetened beverages among individuals with lower socioeconomic position. Nevertheless, other yet unknown factors may also play a role.
- Published
- 2023
- Full Text
- View/download PDF
3. Effects of fructose added to an oral glucose tolerance test on plasma glucose excursions in healthy adults
- Author
-
Amée M. Buziau, Jean L.J.M. Scheijen, Coen D.A. Stehouwer, Casper G. Schalkwijk, and Martijn C.G.J. Brouwers
- Subjects
Oral glucose tolerance test ,Fructose ,Glucose metabolism ,Blood glucose ,Oral fructose ,Humans ,Physiology ,QP1-981 ,Biochemistry ,QD415-436 - Abstract
Background and objective: Previous experimental studies have shown that fructose interacts with glucose metabolism by increasing hepatic glucose uptake. However, human studies investigating the effects of small (‘catalytic’) amounts of fructose, added to an oral glucose load, on plasma glucose levels remain inconclusive. The aim of this study, therefore, was to repeat and extend these previous studies by examining the plasma glucose response during a 75 g oral glucose tolerance test (OGTT) with the addition of different doses of fructose. Methods: Healthy adults (n = 13) received an OGTT without addition of fructose and OGTTs with addition of different doses of fructose (1, 2, 5, 7.5 and 15 g) in a random order, on six separate occasions. Plasma glucose levels were measured every 15 min for 120 min during the study. Findings: The plasma glucose incremental area under the curve (iAUC) of the OGTT without addition of fructose was not significantly different from any OGTT with fructose (p ≥ 0.2 for all fructose doses). Similar results were observed when these data were clustered with data from a similar, previous study (pooled mean difference: 10.6; 95%CI: 45.0; 23.8 for plasma glucose iAUC of the OGTT without addition of fructose versus an OGTT with 5 g fructose; fixed-effect meta-analysis, n = 38). Of interest, serum fructose increased from 4.8 μmol/L (interquartile range: 4.1–5.9) at baseline to 5.3 μmol/L (interquartile range: 4.8–7.5) at T = 60 min during an OGTT without addition of fructose (p = 0.002). Conclusion: Low doses of fructose added to an OGTT do not affect plasma glucose levels in healthy adults. The role of endogenous fructose production, as a potential explanation of these null-findings, deserves further investigation.
- Published
- 2023
- Full Text
- View/download PDF
4. High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
- Author
-
Martijn P.D. Haring, Fabian Peeks, Maaike H. Oosterveer, Martijn C.G.J. Brouwers, Carla E.M. Hollak, Mirian C.H. Janssen, Janneke G. Langendonk, Alexander J.M. Rennings, Margreet A.E.M. Wagenmakers, Henkjan J. Verkade, Terry G.J. Derks, and Vincent E. de Meijer
- Subjects
Benign neoplasm ,Hepatic adenoma ,Glycogen storage disease type Ia ,Metabolic disorder ,Glucose-6-phosphatase triglycerides ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Glycogen storage disease type Ia (GSDIa) is an inborn error of carbohydrate metabolism caused by pathogenic variants in the glucose-6-phosphatase catalytic subunit 1 (G6PC1) gene and is associated with hepatocellular adenoma (HCA) formation. Data on risk factors for HCA occurrence in GSDIa are scarce. We investigated HCA development in relation to sex, G6PC1 genotype, and serum triglyceride concentration (TG). Methods: An observational study of patients with genetically confirmed GSDIa ≥12 years was performed. Patients were categorised for sex; presence of 2, 1, or 0 predicted severe G6PC1 variant (PSV); and median TG during childhood (5.65 mmol/L was associated with HCA development at younger age, compared with patients with childhood TG 5.65 mmol/L as an independent risk factor for HCA development (hazard ratio [HR] 6.0; 95% CI 1.2–29.8; p = 0.028). Conclusions: In patients with GSDIa, high childhood TG was associated with an increased risk of HCA, and earlier onset of HCA development, independent of sex-associated hypertriglyceridaemia, and G6PC1 genotype. Lay summary: Glycogen storage disease type Ia (GSDIa) is a rare, inherited metabolic disease that can be complicated by liver tumours (hepatocellular adenomas), which in turn may cause bleeding or progress to liver cancer. Risk factors associated with hepatocellular adenoma formation in patients with GSDIa are largely unknown. In our study, we found that high serum triglyceride concentrations during childhood, but not specific genetic variants, were associated with increased risk of hepatocellular adenoma diagnosis later in life.
- Published
- 2022
- Full Text
- View/download PDF
5. Kidney and vascular function in adult patients with hereditary fructose intolerance
- Author
-
Nynke Simons, François-Guillaume Debray, Nicolaas C. Schaper, Edith J.M. Feskens, Carla E.M. Hollak, Judith A.P. Bons, Jörgen Bierau, Alfons J.H.M. Houben, Casper G. Schalkwijk, Coen D.A. Stehouwer, David Cassiman, and Martijn C.G.J. Brouwers
- Subjects
Case-control study ,Hereditary fructose intolerance ,Fanconi syndrome ,Kidney ,Blood ,Vessels ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
Objective: Previous studies have shown that patients with hereditary fructose intolerance (HFI) are characterized by a greater intrahepatic triglyceride content, despite a fructose-restricted diet. The present study aimed to examine the long-term consequences of HFI on other aldolase-B-expressing organs, i.e. the kidney and vascular endothelium.Methods: Fifteen adult HFI patients were compared to healthy control individuals matched for age, sex and body mass index. Aortic stiffness was assessed by carotid-femoral pulse wave velocity (cf-PWV) and endothelial function by peripheral arterial tonometry, skin laser doppler flowmetry and the endothelial function biomarkers soluble E-selectin [sE-selectin] and von Willebrand factor. Serum creatinine and cystatin C were measured to estimate the glomerular filtration rate (eGFR). Urinary glucose and amino acid excretion and the ratio of tubular maximum reabsorption of phosphate to GFR (TmP/GFR) were determined as measures of proximal tubular function. Results: Median systolic blood pressure was significantly higher in HFI patients (127 versus 122 mmHg, p = .045). Pulse pressure and cf-PWV did not differ between the groups (p = .37 and p = .49, respectively). Of all endothelial function markers, only sE-selectin was significantly higher in HFI patients (p = .004). eGFR was significantly higher in HFI patients than healthy controls (119 versus 104 ml/min/1.73m2, p = .001, respectively). All measurements of proximal tubular function did not differ significantly between the groups.Conclusions: Adult HFI patients treated with a fructose-restricted diet are characterized by a higher sE-selectin level and slightly higher systolic blood pressure, which in time could contribute to a greater cardiovascular risk. The exact cause and, hence, clinical consequences of the higher eGFR in HFI patients, deserves further study.
- Published
- 2020
- Full Text
- View/download PDF
6. Non-invasive ultrasound-based assessment of ventricular–arterial interaction in vascular Ehlers–Danlos syndrome patients
- Author
-
Koen D. Reesink, Evelien Hermeling, Kim-Thanh Ong, Martijn C.G.J. Brouwers, Robert S. Reneman, Pierre Boutouyrie, and Arnold P.G. Hoeks
- Subjects
Arterial rupture ,Collagen ,Pulse pressure ,Radiofrequency ,Vascular ultrasound ,Ventricular-arterial coupling ,Specialties of internal medicine ,RC581-951 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
The role of ventricular–arterial hemodynamic interaction in the occurrence of arterial dissection and rupture in vascular Ehlers–Danlos syndrome (vEDS) is unknown. We recently introduced an ultrasound-based method to extract, from common carotid artery (CCA) diameter waveforms, central arterial properties and left ventricular (LV) systolic time intervals. We obtained CCA diameters, compliance and distensibility coefficients, and LV isovolumic contraction and ejection periods (ICP and EP) of 19 vEDS patients (aged 27–65 yrs) and 19 age-matched healthy controls. CCA distension and compliance tended to be lower in vEDS subjects (p = 0.062 and p = 0.073), especially in younger patients. ICP (−12 ms) and EP (−24 ms) were shorter (p < 0.001), while heart rate was increased (+10 bpm; p < 0.001) in vEDS. The ICP/EP ratio and estimated isovolumic dPLV/dt indicated increased LV contractility in vEDS. In conclusion, vascular EDS patients tend to have a lower CCA compliance but a normal pulse pressure, most likely reflecting reduced physical fitness.
- Published
- 2010
- Full Text
- View/download PDF
7. Intrahepatic lipid content is independently associated with soluble E-selectin levels: The Maastricht study
- Author
-
Martijn C.G.J. Brouwers, Nynke Simons, Marianne Eline Kooi, Rianneke de Ritter, Martien C.J.M. van Dongen, Simone J.P.M. Eussen, Otto Bekers, Jeroen Kooman, Marleen M.J. van Greevenbroek, Carla J.H. van der Kallen, Miranda T. Schram, Nicolaas C. Schaper, Casper G. Schalkwijk, Coen D.A. Stehouwer, Interne Geneeskunde, MUMC+: MA Endocrinologie (9), RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: Carim - B06 Imaging, Beeldvorming, MUMC+: DA BV Klinisch Fysicus (9), Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, MUMC+: DA CDL (5), MUMC+: DA CDL Analytisch cluster 1K (9), MUMC+: DA CDL Toegelatenen (9), RS: Carim - B01 Blood proteins & engineering, Central Diagnostic Lab, MUMC+: MA Nefrologie (9), RS: NUTRIM - R3 - Respiratory & Age-related Health, MUMC+: HVC Pieken Maastricht Studie (9), RS: Carim - V02 Hypertension and target organ damage, MUMC+: MA Interne Geneeskunde (3), MUMC+: Centrum voor Chronische Zieken (3), MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: MA Maag Darm Lever (9), MUMC+: MA Hematologie (9), MUMC+: MA Medische Oncologie (9), and MUMC+: MA Reumatologie (9)
- Subjects
RISK ,Hepatology ,NASH ,Gastroenterology ,Endothelial Cells ,Vascular Cell Adhesion Molecule-1 ,FATTY LIVER ,Intercellular Adhesion Molecule-1 ,Lipids ,Cohort Studies ,Cross-Sectional Studies ,Diabetes Mellitus, Type 2 ,ENDOTHELIAL DYSFUNCTION ,Humans ,Sinusoidal endothelial cell ,E-Selectin ,Non-alcoholic fatty liver disease - Abstract
BACKGROUND: Evidence is accumulating that liver sinusoidal endothelial cells are involved in the pathogenesis of non-alcoholic fatty liver disease. Previous studies have suggested that the endothelial biomarker soluble E-selectin (sE-selectin) is to an important extent liver-derived.AIMS: To study the relationship of intrahepatic lipid (IHL) content with sE-selectin at the population level.METHODS: This study was conducted in participants of The Maastricht Study (n = 1,634), a population-based cohort study enriched with patients with type 2 diabetes. We assessed the cross-sectional association between IHL content, quantified by MRI, and sE-selectin via multivariable regression with adjustment for age, sex, type 2 diabetes, educational level, BMI, Dutch Healthy Diet index, physical activity, and the Matsuda index.RESULTS: Standardized IHL content was associated with (log) sE-selectin (age-, sex- and type 2 diabetes-adjusted regression coefficient [B]: 0.048 [95%CI:0.038;0.058], pCONCLUSION: IHL content is an independent determinant of sE-selectin at the population level. These findings support further studies to unravel the involvement of liver sinusoidal endothelial cells in the different stages of non-alcoholic fatty liver disease and the specific role of E-selectin herein.
- Published
- 2022
8. Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher Intrahepatic Lipid Content
- Author
-
Amée M. Buziau, Simone J.P.M. Eussen, M. Eline Kooi, Carla J.H. van der Kallen, Martien C.J.M. van Dongen, Nicolaas C. Schaper, Ronald M.A. Henry, Miranda T. Schram, Pieter C. Dagnelie, Marleen M.J. van Greevenbroek, Anke Wesselius, Otto Bekers, Steven J.R. Meex, Casper G. Schalkwijk, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers, Interne Geneeskunde, RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, Beeldvorming, MUMC+: DA BV Klinisch Fysicus (9), RS: Carim - B06 Imaging, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: Carim - V02 Hypertension and target organ damage, MUMC+: HVC Pieken Maastricht Studie (9), RS: NUTRIM - R3 - Respiratory & Age-related Health, Complexe Genetica, MUMC+: DA CDL (5), MUMC+: DA CDL Analytisch cluster 1K (9), MUMC+: DA CDL Toegelatenen (9), RS: Carim - B01 Blood proteins & engineering, Central Diagnostic Lab, Biochemie, MUMC+: DA CDL Algemeen (9), MUMC+: MA Interne Geneeskunde (3), MUMC+: Centrum voor Chronische Zieken (3), MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), and MUMC+: MA Endocrinologie (9)
- Subjects
Male ,Sugar-Sweetened Beverages ,Advanced and Specialized Nursing ,Endocrinology, Diabetes and Metabolism ,Fructose ,Middle Aged ,Lipids ,Beverages ,Cohort Studies ,Fruit and Vegetable Juices ,Cross-Sectional Studies ,Diabetes Mellitus, Type 2 ,Metabolic Diseases ,Fruit ,Internal Medicine ,Humans ,Female ,Aged - Abstract
OBJECTIVE Epidemiological evidence regarding the relationship between fructose intake and intrahepatic lipid (IHL) content is inconclusive. We, therefore, assessed the relationship between different sources of fructose and IHL at the population level. RESEARCH DESIGN AND METHODS We used cross-sectional data from The Maastricht Study, a population-based cohort study (n = 3,981; mean ± SD age: 60 ± 9 years; 50% women). We assessed the relationship between fructose intake (assessed with a food-frequency questionnaire)—total and derived from fruit, fruit juice, and sugar-sweetened beverages (SSB)—and IHL (quantified with 3T Dixon MRI) with adjustment for age, sex, type 2 diabetes, education, smoking status, physical activity, and intakes of total energy, alcohol, saturated fat, protein, vitamin E, and dietary fiber. RESULTS Energy-adjusted total fructose intake and energy-adjusted fructose from fruit were not associated with IHL in the fully adjusted models (P = 0.647 and P = 0.767). In contrast, energy-adjusted intake of fructose from fruit juice and SSB was associated with higher IHL in the fully adjusted models (P = 0.019 and P = 0.009). Individuals in the highest tertile of energy-adjusted intake of fructose from fruit juice and SSB had a 1.04-fold (95% CI 0.99; 1.11) and 1.09-fold (95% CI 1.03; 1.16) higher IHL, respectively, in comparison with the lowest tertile in the fully adjusted models. Finally, the association for fructose from fruit juice was stronger in individuals with type 2 diabetes (P for interaction = 0.071). CONCLUSIONS Fructose from fruit juice and SSB is independently associated with higher IHL. These cross-sectional findings contribute to current knowledge in support of measures to reduce the intake of fructose-containing beverages as a means to prevent nonalcoholic fatty liver disease at the population level.
- Published
- 2022
9. Effects of fructose restriction on blood pressure: Secondary analysis of a double-blind randomized controlled trial
- Author
-
Lise E.F. Janssen, Nynke Simons, Pomme I.H.G. Simons, Nicolaas C. Schaper, Edith J.M. Feskens, Liesbeth M.C. van der Ploeg, Mathias D.G. Van den Eynde, Casper G. Schalkwijk, Alfons J.H.M. Houben, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers, Interne Geneeskunde, RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: Carim - V02 Hypertension and target organ damage, MUMC+: TPZ Dietetiek (9), MUMC+: MA Interne Geneeskunde (3), and MUMC+: MA Endocrinologie (9)
- Subjects
Global Nutrition ,Wereldvoeding ,Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Selectins/pharmacology ,Dietary ,Powders/pharmacology ,Fructose ,Sodium Chloride ,Dietary intervention ,Glucose ,Randomized controlled trial ,Selectins ,Blood pressure ,Humans ,Endothelial dysfunction ,Powders ,Sodium Chloride, Dietary ,VLAG ,Nutrition - Abstract
Background: Despite convincing animal data, there is an ongoing debate on whether and how fructose affects blood pressure in humans. The aim of this study was to investigate the effects of fructose restriction on blood pressure, and the role of endothelial function herein. Methods: forty-four overweight individuals were asked to follow a fructose-restricted diet (
- Published
- 2022
10. Association between de novo lipogenesis susceptibility genes and coronary artery disease
- Author
-
Pomme I.H.G. Simons, Olivier Valkenburg, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers, RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, Interne Geneeskunde, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), Obstetrie & Gynaecologie, RS: GROW - R4 - Reproductive and Perinatal Medicine, MUMC+: MA Interne Geneeskunde (3), and MUMC+: MA Endocrinologie (9)
- Subjects
Nutrition and Dietetics ,Liver ,Non-alcoholic Fatty Liver Disease ,Lipogenesis ,Endocrinology, Diabetes and Metabolism ,Fatty Acids ,Humans ,Medicine (miscellaneous) ,Coronary Artery Disease ,Cardiology and Cardiovascular Medicine - Abstract
BACKGROUND AND AIMS: Coronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use genetic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.METHODS AND RESULTS: DNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (∼76014 cases and ∼264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibility genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996-1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).CONCLUSIONS: DNL susceptibility genes are associated with an increased risk of CAD. These findings suggest that DNL may be involved in the pathogenesis of CAD and favor further development of strategies that target NAFLD through DNL.
- Published
- 2022
11. Comment on Lee et al. Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care 2022;45:1917–1930
- Author
-
Amée M. Buziau, Gabriëlla A.M. Blokland, Casper G. Schalkwijk, Jean L.J.M. Scheijen, Pomme I.H.G. Simons, Simone J.P.M. Eussen, Pieter C. Dagnelie, Marleen M.J. van Greevenbroek, Anke Wesselius, Coen D.A. Stehouwer, and Martijn C.G.J. Brouwers
- Subjects
Advanced and Specialized Nursing ,Endocrinology, Diabetes and Metabolism ,Internal Medicine - Published
- 2023
12. Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
- Author
-
Judith van Dalem, Nikki C.C. Werkman, Joop P. van den Bergh, Bernardette Rossi, Rikke Viggers, Richard Eastell, Andrea M. Burden, Coen D.A. Stehouwer, Olaf H. Klungel, Martijn C.G.J. Brouwers, Johanna H.M. Driessen, RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, MUMC+: DA KFT Medische Staf (9), Clinical Pharmacy, RS: NUTRIM - R3 - Respiratory & Age-related Health, Interne Geneeskunde, RS: CAPHRI - R5 - Optimising Patient Care, MUMC+: MA Interne Geneeskunde (3), and MUMC+: MA Endocrinologie (9)
- Subjects
Adult ,Symporters ,Endocrinology, Diabetes and Metabolism ,Sodium ,General Medicine ,Body Mass Index ,Type 2 diabetes mellitus ,Sodium-glucose co-transporter-2 inhibitors ,BMI ,Fracture ,Cohort study ,Cohort Studies ,Glucose ,Sulfonylurea Compounds ,Endocrinology ,Diabetes Mellitus, Type 2 ,Internal Medicine ,Humans ,Hypoglycemic Agents ,Sodium-Glucose Transporter 2 Inhibitors ,Osteoporotic Fractures ,Retrospective Studies - Abstract
Aims: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a role in the debated elevated fracture risk with these agents. The aim of the current study was to investigate the association between SGLT-2 inhibitor use, changes in body mass index (BMI) and fracture risk. Methods: A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD) GOLD (2013–2018). The study population (N = 34,960) consisted of adults with diabetes initiating a sulphonylurea or SGLT-2 inhibitor. Cox proportional hazards models estimated hazard ratios (HRs) for major osteoporotic fracture with SGLT-2 inhibitor use versus sulphonylurea use, stratified by change in BMI, average daily dose and cumulative dose. Analyses were adjusted for age, sex, lifestyle variables, comorbidities, and concomitant drug use. Results: SGLT-2 inhibitor use was not associated with an increased fracture risk compared to sulphonylurea use (adjusted HR 1.19; 95% confidence interval (CI): 0.80–1.79). This finding remained consistent after stratification by BMI change. However, the highest cumulative dose category was associated with an increased fracture risk (adjusted HR: 2.10, 95 %CI: 1.11–3.99). Conclusion: SGLT-2 inhibitor use was not associated with increased osteoporotic fracture risk, irrespective of change in BMI. However, a high cumulative dose could be an important risk factor., Diabetes Research and Clinical Practice, 190
- Published
- 2022
13. Novel insights in intestinal and hepatic fructose metabolism: from mice to men
- Author
-
Evi Koene, Vera B. Schrauwen-Hinderling, Patrick Schrauwen, and Martijn C.G.J. Brouwers
- Subjects
nonalcoholic fatty liver disease ,Nutrition and Dietetics ,INHIBITION ,aldolase B ,Medicine (miscellaneous) ,colorectal cancer ,SUGAR ,Fructose ,Lipid Metabolism ,MICROBIOTA ,Lipids ,DIETARY FRUCTOSE ,GLUCOSE ,Intestines ,ketohexokinase ,LIPOGENESIS ,Liver ,Cardiovascular Diseases ,Non-alcoholic Fatty Liver Disease ,LIVER FAT ,Animals ,Humans ,GLUCOKINASE - Abstract
PURPOSE OF REVIEW: The rise in fructose consumption in parallel with the current epidemic of obesity and related cardiometabolic disease requires a better understanding of the pathophysiological pathways that are involved. RECENT FINDINGS: Animal studies have shown that fructose has various effects on the intestines that subsequently affect intrahepatic lipid accumulation and inflammation. Fructose adversely affects the gut microbiome - as a producer of endotoxins and intermediates of de novo lipogenesis - and intestinal barrier function. Furthermore, intestinal fructose metabolism shields fructose away from the liver. Finally, fructose 1-phosphate (F1-P) serves as a signal molecule that promotes intestinal cell survival and, consequently, intestinal absorption capacity. Intervention and epidemiological studies have convincingly shown that fructose, particularly derived from sugar-sweetened beverages, stimulates de novo lipogenesis and intrahepatic lipid accumulation in humans. Of interest, individuals with aldolase B deficiency, who accumulate F1-P, are characterized by a greater intrahepatic lipid content. First phase II clinical trials have recently shown that reduction of F1-P, by inhibition of ketohexokinase, reduces intrahepatic lipid content. SUMMARY: Experimental evidence supports current measures to reduce fructose intake, for example by the implementation of a tax on sugar-sweetened beverages, and pharmacological inhibition of fructose metabolism to reduce the global burden of cardiometabolic disease.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.